TG Therapeutics
- Market cap
- 8.11B
- P/E (TTM)i
- 19.32
- P/Bi
- 13.42
- EPSi
- 2.77
- Div yieldi
- 0.00%
- 52W posi
- 80%
Anonymous reader poll. Unscientific, not investment advice.
TG Therapeutics shares were changing hands at 52.95, up 1.46% on the day. At current prices, the business is worth about 8.11B, the #1638 most valuable US-listed company we track. Trading at a P/E of 19.28, the stock is 203% above its own five-year norm of 6.37. The 6 analysts covering the stock are, on balance, at Buy, targeting an average of 69.17 (+31%). Against a 52-week band of 26.76-59.30, the shares are currently 80% of the way up.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 20% of the universe, above its 200-day average.
- Signal has read BUY for 2 months.
- Its last 5 Buy calls have averaged +28% over the following quarter.
- Recent price momentum is +18.1% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 19.7% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 52.19
- Open
- 51.83
- Day range
- 51.41 - 53.88
- Avg price
- 53.06
- Volume
- 1.51M
- Turnover
- 79.93M
- Turnover ratei
- 1.03%
- Volume ratioi
- 0.78
- Amplitudei
- 4.74%
- 52-week rangei
- 26.76 - 59.30
Valuation
- P/Ei
- 19.12
- P/E (TTM)i
- 19.32
- P/Bi
- 13.42
- EPSi
- 2.77
- Book value / shi
- 3.95
- Net profit
- 424.00M
- Net assets
- 604.01M
Share structure
- Market cap
- 8.11B
- Float capi
- 7.76B
- Shares out
- 153.07M
- Float sharesi
- 146.46M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
10.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+2.04M net over the window
Short interest
- Shares short
- 30.15M
- % of floati
- 19.70%
- Days to coveri
- 18.54
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of TG Therapeutics (TGTX)?
TG Therapeutics last traded at 52.95. The quote on this page refreshes every few seconds while US markets are open.
What is TG Therapeutics's market cap?
About 8.11B.
What is the P/E ratio of TG Therapeutics?
The trailing twelve-month P/E is 19.32, above its own 5-year average of 6.37 — toward the top of its historical range (69.35% percentile). See the Valuation tab for the full history.
Does TG Therapeutics pay a dividend?
TG Therapeutics does not currently pay a regular dividend.
Is TG Therapeutics a buy according to analysts?
The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 69.17, which implies 30.6% upside from the current price. This is not investment advice.
What is TG Therapeutics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates TG Therapeutics a B (Buy). Twelve-month momentum in the top 20% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 08:09:24 · For reference only, not investment advice and not tailored to your situation.